James Shannon, Ronald Brus and Dennis Akkaya discuss the impact of the debate on the Right-to-Try laws in the US and what needs to be done to improve access to innovative drugs.
Many pharma companies have corporate social responsibility (CSR) departments, but some are going further and putting access to medicine at the core of their businesses. Jayasree K.
Cancer Research UK (CRUK) has said it will award £123 million ($150 million) in funding over the next seven years to Scotland’s Beatson Institute, which will be renamed th
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho